Cipla (EU) Limited, wholly owned subsidiary of Cipla Limited in UK, has entered into a joint venture agreement with Kemwell Biopharma UK Limited and MNI Ventures, Mauritius on 5th January, 2024 for incorporation of a joint venture company in USA.

The JV entity is being incorporated with an objective of commercialising novel cell therapy products in USA, Japan and EU region.